EGS receives $30.5M to advance minimally invasive GERD Technique
EndoGastric Solutions has raised $30.5 million to commercialize its minimally invasive procedure aimed at patients with gastroesophageal reflux
EndoGastric Solutions has raised $30.5 million to commercialize its minimally invasive procedure aimed at patients with gastroesophageal reflux
EndoGastric Solutions' well funded TIF procedure is meant to improve acid reflux issues in those with serious GERD.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
EndoGastric Solutions has raised more than $160 million for its device that one-ups laparoscopy - it helps surgeons conduct stomach surgery through the mouth, so no incisions need to be made.